ARTIVA BIOTHERAPEUTICS INC. - COMMON STOCK

Artiva Biotherapeutics to Participate in the Jefferies Global Healthcare Conference

28 май 2025 13:05:00 Источник Nasdaq GlobeNewswire

Artiva Biotherapeutics Announces Longer-term Phase 1/2 Data Demonstrating Prolonged Durability for AlloNK® in Combination with Rituximab in Patients with B-cell-Non-Hodgkin Lymphoma at the ASGCT 28th Annual Meeting

13 май 2025 13:05:00 Источник Nasdaq GlobeNewswire

Artiva Biotherapeutics Reports First Quarter 2025 Financial Results, Recent Business Highlights

08 май 2025 05:00:00 Источник Nasdaq GlobeNewswire

Artiva Biotherapeutics to Present Longer-term Phase 1/2 Data for AlloNK® in Combination with Rituximab in Patients with B-cell-Non-Hodgkin Lymphoma at the ASGCT 28th Annual Meeting

28 апр 2025 13:35:00 Источник Nasdaq GlobeNewswire

Artiva Biotherapeutics Appoints Subhashis Banerjee, M.D., as Chief Medical Officer

08 апр 2025 13:05:00 Источник Nasdaq GlobeNewswire

Artiva Biotherapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference

31 мар 2025 13:05:00 Источник Nasdaq GlobeNewswire

Artiva Biotherapeutics Reports Full Year 2024 Financial Results and Recent Business Highlights

24 мар 2025 13:05:00 Источник Nasdaq GlobeNewswire

Artiva Biotherapeutics to Participate in the TD Cowen 45th Annual Health Care Conference

20 фев 2025 13:05:00 Источник Nasdaq GlobeNewswire

Artiva Biotherapeutics Expands Board of Directors with Appointment of Dan Baker, M.D.

29 янв 2025 13:05:00 Источник Nasdaq GlobeNewswire

Artiva Biotherapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights

12 ноя 2024 13:05:01 Источник Nasdaq GlobeNewswire

Artiva Biotherapeutics to Participate in the Jefferies London Healthcare Conference

11 ноя 2024 13:05:00 Источник Nasdaq GlobeNewswire

Artiva Biotherapeutics Appoints Alison Moore, Ph.D., to Its Board of Directors

22 окт 2024 13:05:00 Источник Nasdaq GlobeNewswire

Artiva Biotherapeutics to Participate in the 2024 Cantor Fitzgerald Global Healthcare Conference

10 сен 2024 13:05:00 Источник Nasdaq GlobeNewswire

Artiva Biotherapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights

29 авг 2024 13:05:00 Источник Nasdaq GlobeNewswire

Artiva Biotherapeutics Announces Pricing of Upsized $167.0 Million Initial Public Offering

18 июл 2024 16:08:52 Источник Nasdaq GlobeNewswire